TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2015

Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003).

Nancy U Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.